Challenges in the nephrology industry—including the shift away from fee-for-service to value-based payments—are pushing physicians to consider different business models. Partnering with another organization may…

Practicing medicine in today’s health care environment is not for the faint of heart. Historically, successful practices were predicated on providing high-quality patient care; i.e.,…

Discussions on ways to leverage telehealth (two-way video visits between physicians and their patients) are accelerating across numerous medical organizations, health care providers, insurance carriers,…

End stage renal disease (ESRD) patients compose one of the most costly and complex patient populations, requiring substantial coordination and communication across the care spectrum…

The Medicare Access and CHIP Reauthorization Act (MACRA) is an evolution of existing programs that physicians have been participating in over the last few years….

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) went into effect January 1, 2017. MACRA determines reimbursement for physicians receiving Medicare Part B…

The Comprehensive ESRD Care Model was designed by CMS to test new ways to evaluate and improve care for Medicare beneficiaries with ESRD through new…

End stage renal disease (ESRD) represents a population health conundrum. It affects a relatively small part of the U.S. population—only 600,000 individuals. Yet the rate…

With responsibilities typically spanning across a high number of patients and administrative tasks, it is imperative for physicians to effectively manage their time to maintain…

There has been much confusion and angst surrounding the regulation rollout of the Medicare Access and CHIP Reauthorization Act (MACRA). The rule is complex, requiring…